3,3,9,9-Tetraethyl-4,8-dioxa-3,9-disilaundecan-6-one, 98%, 5g

4-Phenoxyphenylacetic acid, 98.0%, 100g

2-(4-METHOXYPHENYL)-3-METHYL-5-METHOXYINDOLE, 95.0%, 1g

(5-aminopentyl)(diazyn-1-ium-1-yl)azanide, 10g

(S)-2-Aminooctanoic acid, 95.0%, 1g

Eosina Y (CI 45380), 500 g

3-(((7R,8R,9S,13S,14S,17S)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-7-yl)thio)propanoic acid, 97%, 10mg

Conexión de junta esférica, 13/5, 100 mm, 10 Pieza(s)

(s)-2-Amino-2-(4-bromo-2,6-difluorophenyl)ethan-1-ol, 95%, 250mg

1,2,3,4-Tetrahydronaphthalene>97.0%(GC)500mL

Methyl 1H-pyrrolo[3,2-c]pyridine-4-carboxylate, 95.0%, 1g

(S)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 5g

Methyl 4-(5-isoxazolyl)benzoate, 5g